iRhythm Technologies, Inc. (IRTC)
NASDAQ: IRTC · Real-Time Price · USD
102.93
+3.44 (3.46%)
Apr 23, 2025, 4:00 PM EDT - Market closed
iRhythm Technologies Revenue
In the year 2024, iRhythm Technologies had annual revenue of $591.84M with 20.13% growth. iRhythm Technologies had revenue of $164.33M in the quarter ending December 31, 2024, with 24.01% growth.
Revenue (ttm)
$591.84M
Revenue Growth
+20.13%
P/S Ratio
5.41
Revenue / Employee
$295,920
Employees
2,000
Market Cap
3.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 591.84M | 99.16M | 20.13% |
Dec 31, 2023 | 492.68M | 81.76M | 19.90% |
Dec 31, 2022 | 410.92M | 88.10M | 27.29% |
Dec 31, 2021 | 322.83M | 57.66M | 21.74% |
Dec 31, 2020 | 265.17M | 50.61M | 23.59% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
IRTC News
- 6 days ago - iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 - GlobeNewsWire
- 8 days ago - iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability - GlobeNewsWire
- 24 days ago - iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection - GlobeNewsWire
- 2 months ago - iRhythm Technologies, Inc. (IRTC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Shareholders to Learn More About the Investigation - Accesswire